|
⚲
|
| Keyboard |
| Pallares Ebetuel
✚
|
|
|---|---|
| CIK # | 0001614597 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001614597] | |
| 4 | [0001614597] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Pallares Ebetuel | |
| Exagen Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Exagen Inc XGN
Stock Option(right to buy) · derivative
|
2023-06-09 | Grant | 9,000 | $0.00 | |
|
Exagen Inc XGN
Stock Option(right to buy) · derivative
|
2022-06-16 | Grant | 9,000 | $0.00 | |
|
Exagen Inc XGN
Stock Option(right to buy) · derivative
|
2021-06-17 | Grant | 9,000 | $0.00 | |
|
Exagen Inc XGN
Stock Option(right to buy) · derivative
|
2020-06-18 | Grant | 9,000 | $0.00 | |
|
Exagen Inc XGN
Common Stock
|
2020-04-13 | Other | 1,185 | $0.00 | |
|
Exagen Inc XGN
Common Stock
|
2020-04-13 | Other | 144,033 | $0.00 | |
|
Exagen Inc XGN
Common Stock
|
2020-03-11 | Option exercise | 2,265 | $1.84 | 4,168 |
|
Exagen Inc XGN
Common Stock
|
2020-03-11 | Tax withheld | 214 | $19.51 | 4,175 |
|
Exagen Inc XGN
Common Stock
|
2020-03-11 | Tax withheld | 2,112 | $19.51 | 41,205 |
|
Exagen Inc XGN
Common Stock
|
2020-03-11 | Option exercise | 22,427 | $1.84 | 41,266 |
|
Exagen Inc XGN
Warrants · derivative
|
2020-03-11 | Option exercise | 2,265 | $0.00 | |
|
Exagen Inc XGN
Warrants · derivative
|
2020-03-11 | Option exercise | 22,427 | $0.00 | |
|
Exagen Inc XGN
Series E Redeemable Convertible Preferred Stock · derivative
|
2019-09-23 | Conversion | 4,423,371 | ||
|
Exagen Inc XGN
Series F Redeemable Convertible Preferred Stock · derivative
|
2019-09-23 | Conversion | 7,970,686 | ||
|
Exagen Inc XGN
Common Stock
|
2019-09-23 | Conversion | 120,609 | $0.00 | |
|
Exagen Inc XGN
Common Stock
|
2019-09-19 | Tax withheld | 2,960 | $18.58 | 54,997 |
|
Exagen Inc XGN
Warrants · derivative
|
2019-09-19 | Option exercise | 3,839 | $14.32 | 54,974 |
|
Exagen Inc XGN
Common Stock
|
2019-09-19 | Option exercise | 3,839 | $14.32 | 54,974 |